We examined the effects of 72-h exposure to atorvastatin and rosuvastatin in concentrations of 2-10 nM on the cytokine expression in LPS/IFNγ-activated monocyte/macrophages derived from peripheral blood monocytes of healthy donors by culturing in the presence of GM-CSF. Pretreatment with statins was found to inhibit cytokine production in monocytes/macrophages after activation, while the level of cytokine mRNA in cells did not decrease. The number of cells containing active caspase-3 decreased in the culture. Culturing of monocytes/macrophages with statins was accompanied by changes in cell morphology and deceleration of cell growth. Cellular effects of “lipophilic” atorvastastin were observed at lower concentration compared to “hydrophilic” rosuvastatin.
Similar content being viewed by others
References
Filatova AYu, Potekhina AV, Ruleva NYu, Radyukhina NV, Arefieva TI. The influence of atorvastatin and rosuvastatin in atherosclerosis on the parameters of cellular immunity and in vitro leucocyte activation. Ross. Kardiol. Zh. 2018;23(8):59- 64. doi: https://doi.org/10.15829/1560-4071-2018-8-59-64. Russian.
Arefieva TI, Filatova AY, Potekhina AV, Shchinova AM. Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins). Biochemistry (Mosc). 2018;83(8):874-889. doi: https://doi.org/10.1134/S0006297918080023
Björkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br. J. Clin. Pharmacol. 2011;72(1):164-165. doi: https://doi.org/10.1111/j.1365-2125.2011.03907.x
Boland AJ, Gangadharan N, Kavanagh P, Hemeryck L, Kieran J, Barry M, Walsh PT, Lucitt M. Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals. J. Cardiovasc. Pharmacol. Ther. 2018;23(6):509-517. doi: https://doi.org/10.1177/1074248418776261
Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 2000;36(2):427-431.
Hodgkinson CP, Ye S. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression. Pharmacogenet. Genomics. 2008;18(9):803-813. doi: https://doi.org/10.1097/FPC.0b013e3283050aff
Kiener PA, Davis PM, Murray JL, Youssef S, Rankin BM, Kowala M. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. Int. Immunopharmacol. 2001;1(1):105-118.
Krysiak R, Okopien B. The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia. J. Cardiovasc. Pharmacol. 2011;57(4):505- 512. doi: https://doi.org/10.1097/FJC.0b013e318211703b
Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 2003;23(5):769-775.
Matsumoto M, Einhaus D, Gold ES, Aderem A. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J. Immunol. 2004;172(12):7377-7384.
Methe H, Kim JO, Kofler S, Nabauer M, Weis M. Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. Arterioscler. Thromb. Vasc. Biol. 2005;25(7):1439-1445.
Nakagomi A, Seino Y, Kohashi K, Kosugi M, Endoh Y, Kusama Y, Atarashi H, Mizuno K. Effects of statin therapy on the production of monocyte proinflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia. Circ. J. 2012;76(9):2130-2138.
Sasidhar MV, Chevooru SK, Eickelberg O, Hartung HP, Neuhaus O. Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. PLoS One. 2017;12(12):e0189701. doi: https://doi.org/10.1371/journal.pone.0189701
Yang J, Pan Y, Li X, Wang X. Atorvastatin attenuates cognitive deficits through Akt1/caspase-3 signaling pathway in ischemic stroke. Brain Res. 2015;1629:231-239. doi: https://doi.org/10.1016/j.brainres.2015.10.032
Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69-75. doi: https://doi.org/10.1111/imm.12902
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 8, pp. 209-214, August, 2020
Rights and permissions
About this article
Cite this article
Ruleva, N.Y., Radyukhina, N.V., Zubkova, E.S. et al. Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (Statins) Suppress Differentiation and Reduce LPS/IFNγ-Induced Cytokine Production in Human Monocyte/Macrophage Culture. Bull Exp Biol Med 170, 236–240 (2020). https://doi.org/10.1007/s10517-020-05042-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-05042-x